Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2034 of 6351
-
App and peer support aim to boost HIV prevention for people leaving jail
Prevention CompletedThis study will provide HIV prevention and related support services to men who have sex with men and transgender women who have substance use disorders and are either leaving jail or recently released from jail. The researchers will compare the utilization of HIV prevention and o…
Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
Can a vaccine stop head and neck cancer from coming back?
Disease control CompletedThis study has been designed to evaluate the safety and efficacy of giving seven injections of PepCan or placebo over approximately a 24-month period in subjects with head and neck cancers who achieved remission. PepCan may prove to be beneficial in treating many stages of HPV-re…
Phase 1/2 • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug combo after transplant shows promise for tough hodgkin lymphoma
Disease control CompletedThe aim of the trial is to improve disease control after an allogeneic stem cell transplantation (alloSCT) for relapsed or refractory classical Hodgkin lymphoma (rrHL, cHL) with consolidation therapy by Brentuximab Vedotin (BV) for up to one year. The primary objective of the tr…
Phase 2 • Sponsor: University of Cologne • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New dosing study aims to protect kids from latent TB
Disease control CompletedHypotheses: Rifapentine (given as water-dispersible monolayer and/or fixed dose combination with isoniazid) dosing in HIV-infected and uninfected children ≤ 12 years of age with latent TB infection (LTBI) or with exposure to Mycobacterium tuberculosis (M. tuberculosis) will requi…
Phase 1/2 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New hope for CLL patients: umbralisib shows promise in early trial
Disease control Stopped earlyThe purpose of this study is to see how safe and effective the investigational drug umbralisib (TGR-1202) is in individuals with Chronic Lymphocytic Leukemia (CLL)
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a scalp cap read the brain as well as implanted wires?
Knowledge-focused CompletedImprove understanding of the correlation between surface EEG and implanted EEG recordings
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Could a cartoon or video game take the sting out of allergy tests for kids?
Symptom relief CompletedThis randomized controlled trial compared three distraction techniques-animated cartoons, DistrACTION® Cards, and interactive video games-with standard care for reducing procedural pain and anxiety in children aged 6-10 years undergoing allergy skin prick testing. A total of 161 …
Sponsor: Istanbul University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New combo treatment aims to help veterans quit smoking and manage PTSD
Disease control CompletedSmoking is the leading cause of preventable illness, disability, and death in the United States. The rate of smoking is disproportionately higher among Veterans with posttraumatic stress disorder (PTSD). Unfortunately, smoking cessation efforts that are effective in the general p…
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug BT5528 targets Hard-to-Treat cancers in early trial
Disease control OngoingThis clinical trial is evaluating a drug called BT5528 alone and in combination with nivolumab in participants with advanced solid tumors historically known for expression of EphA2. The main goals of this study are to: * Find the recommended dose(s) of BT5528 that can be given s…
Phase 1/2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a condensed radiation blast plus chemo keep esophageal cancer at bay?
Disease control OngoingRates of local disease control in patients with locally advanced esophageal cancer who are not candidates for surgical resection are suboptimal. Despite treatment with chemotherapy and radiation therapy approximately half of patients will develop recurrence of their cancer at the…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug shows promise for Hard-to-Treat cancers with specific gene flaw
Disease control CompletedThis study is a Phase 1b/2a basket trial to assess safety and efficacy of IDX-1197 in patients with HRR mutation. There are two parts to this study: Phase 1b, IDX-1197 dose-selection study to determine RP2D and Phase 2a, non-randomized parallel dose expansion study to confirm RP…
Phase 1/2 • Sponsor: Idience Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Gene therapy targets Alzheimer's in High-Risk group
Disease control CompletedThis clinical trial is an open label, dose-ranging study designed to evaluate gene therapy to treat patients who are APOE4 homozygotes with clinical diagnosis varying from mild cognitive impairment due to Alzheimer's, mild dementia due to Alzheimer's disease, and moderate dementi…
Phase 1/2 • Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for pancreatic cancer? early trial combines novel drug with chemo and immunotherapy
Disease control CompletedThis is a Phase 1, open-label, dose-escalation, and dose-expansion, with a gated randomization portion, study to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic and clinical activity of AB680 in combination with zimberelimab (AB122), nab-paclitaxel and gemcita…
Phase 1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo shows promise for tough stomach cancers
Disease control CompletedThe objective of the study is to evaluate Tolerability, Safety, and primary Efficacy of Gentuximab Injection at different dosage in combination with Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer patients, to ensure adequate treatment dosage for further study.…
Phase 1/2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can new tracers make many cancers light up on scans?
Diagnosis OngoingThis phase I trial studies a new imaging technique called FAPi PET/CT to determine where and to which degree the FAPI tracer (68Ga-FAPi-46) accumulate in normal and cancer tissues in patients with non-prostate cancer. The research team also want to know whether what they see on P…
Early phase 1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Aug 23, 2026 00:00 UTC
-
New drug takes on KRAS: early trial launches for Hard-to-Treat cancers
Disease control OngoingThis is a study in adults with advanced cancer (solid tumours) in whom previous chemotherapy was not successful. Only people who have a tumour with a KRAS mutation can participate in the study. A KRAS mutation makes cancer grow faster. The study tests 2 medicines called BI 17019…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New hope for women with vestibulodynia: cream and pill combo under study
Symptom relief CompletedVestibulodynia (VBD) is a complex chronic vulvar pain condition that impairs the psychological, physical, and sexual health of 1 in 6 reproductive aged women in the United States. Here, the investigators plan to conduct a randomized, double-blinded, placebo-controlled clinical tr…
Phase 2 • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Kids' brain tumor drugs tested for Long-Term safety
Disease control OngoingA roll-over study to assess long-term effect in pediatric patients treated with dabrafenib and/or trametinib.
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Super-Sized flu shot tested for Seniors' heart and lung protection
Prevention Stopped earlyPrimary Objective: To demonstrate the superior relative effectiveness of QIV-HD as compared to QIV-SD among persons 65 years of age and older for the prevention of cardiovascular and/or respiratory hospitalizations. Secondary Objective: * To assess the clinical relative effect…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 26, 2026 17:31 UTC
-
New tool could help spot TB in starving children
Diagnosis CompletedTB-Speed SAM is a multicentric, prospective diagnostic cohort study conducted in two countries with high and very high TB incidence (Uganda and Zambia). It aims at assessing several diagnostic tests that could result in the development of a score and algorithm for TB treatment de…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC